N-(4-fluorophenyl)benzo[d]thiazol-2-amine
CAS No. 348-45-8
N-(4-fluorophenyl)benzo[d]thiazol-2-amine( —— )
Catalog No. M28897 CAS No. 348-45-8
N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 44 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 79 | In Stock |
|
| 25MG | 166 | In Stock |
|
| 50MG | 230 | In Stock |
|
| 100MG | 334 | In Stock |
|
| 200MG | 455 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-(4-fluorophenyl)benzo[d]thiazol-2-amine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
-
DescriptionN-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCYP17
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number348-45-8
-
Formula Weight244.29
-
Molecular FormulaC13H9FN2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (511.69 mM)
-
SMILESFc1ccc(Nc2nc3ccccc3s2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
(Tyr1)-TRAP-7
YFLLRNP is a biological active peptide. (a partial agonist of PAR-1. YFLLRNP selectively active G12/13 signaling pathway without activating Gq or Gi pathways at low concentrations. YFLLRNP (60 μM))
-
Chiniofon
Chiniofon, a halogenated 8-hydroxyquinoline, is used as an antiamebic drug. This type of anti-amebic drug exerts an anti-amebic effect by inhibiting intestinal commensal bacteria and affects amoebic dysentery, but has no effect on extra-intestinal amoebic parasites.
-
MSC2504877
MSC2504877 is an inhibitor of tankyrase and enhances the effects of clinical CDK4/6 inhibitors. MSC2504877 suppresses the upregulation of Cyclin D2 and Cyclin E2 caused by palbociclib and enhances the suppression of phospho-Rb.
Cart
sales@molnova.com